UPDATED Aug 18, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €4.50 | -4.3% | -27.7% | €126.0m | €12.30 | 15.9 | 98.0% | n/a | ||
ARGX | €877.60 | 15.3% | 55.8% | €54.9b | €934.68 | 37.4 | 24.2% | n/a | ||
UCB | €217.80 | -1.8% | 11.6% | €41.5b | €285.26 | 18.9 | 13.8% | 0.7% | ||
CYAD | €0.27 | 1.1% | -30.0% | €13.0m | n/a | 14.7 | n/a | n/a | ||
BIOS | €0.002 | 0% | -23.1% | €1.3m | n/a | -0.3 | n/a | n/a | ||
OXUR | €0.0028 | 7.7% | -89.0% | €248.3k | n/a | -0.1 | n/a | n/a | ||
TUB | €184.80 | -1.1% | 16.7% | €8.2b | €286.00 | 83.6 | n/a | 0.6% |